Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa

OBJECTIVE: WHO recommends ritonavir-boosted protease inhibitor with two nucleoside reverse transcriptase inhibitors in HIV-infected patients failing non-nucleoside reverse transcriptase inhibitor-based first-line treatment. Here, we aimed to provide more evidence for the choice of nucleoside reverse...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :AIDS
Главные авторы: Ciaffi, Laura, Koulla-Shiro, Sinata, Sawadogo, Adrien, le Moing, Vincent, Eymard-Duvernay, Sabrina, Izard, Susanne, Kouanfack, Charles, Ngom Gueye, Ndeye Fatou, Fobang, Avelin Aghokeng, Reynes, Jacques, Calmy, Alexandra, Delaporte, Eric
Формат: Artigo
Язык:Inglês
Опубликовано: Lippincott Williams & Wilkins 2015
Предметы:
Clinical Science
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4502989/
https://ncbi.nlm.nih.gov/pubmed/26244387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000000709
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы